Started doing research in Catalyst Pharmaceuticals $Catalyst Pharmaceuticals(CPRX)$. Company has been pretty flat year to date. Financials look more than strong. Free cash flow and cash equivalents have been increasing anually and quarterly.
Even better:
Shareholder's equity has been increasing. Up more than 100% since 2023.
Retained earnings has been positive since 2022.
Some media coverage here and there.
CEO has an MBA and most importantly, Bsc in Microbiology.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
